We recommend this service for patients who believe they are at high risk for ovarian, prostate, liver or thyroid cancer due to family history, or presence of symptoms, or patients that have been previously diagnosed and wish to monitor their tumour marker levels during, or after treatment. Abnormal tumour markers may indicate a form of cancer within the body from as early as early stage 1, upto stage 4.